This document is a publication of a European patent application (EP4525868A1) by CinDome Pharma, Inc. The patent covers the use of deuterated domperidone for the treatment of gastroparesis. The application was published on March 18, 2026, and lists Mary Bond, Brendan Doran, Brian Murphy, and Jon Isaacsohn as inventors.

This publication represents a new patent filing and does not impose immediate compliance obligations on regulated entities. However, it is relevant for pharmaceutical companies and drug manufacturers operating in the European Union, particularly those involved in the development or manufacturing of treatments for gastrointestinal disorders. Compliance officers should note this filing as part of ongoing intellectual property and competitive landscape monitoring.